Report Detail

Request for Sample of this report

Pharma & Healthcare Global Infantile Spasms Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2938752
    • |
  • 13 February, 2019
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

Scope of the Report:
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.
The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.
Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.
United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.
The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.
In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
The worldwide market for Infantile Spasms Therapeutics is expected to grow at a CAGR of roughly 3.0% over the next five years, will reach 150 million US$ in 2024, from 130 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Infantile Spasms Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Injection

Market Segment by Applications, can be divided into
Hospital
Clinic

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Infantile Spasms Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Infantile Spasms Therapeutics, with price, sales, revenue and global market share of Infantile Spasms Therapeutics in 2017 and 2018.
Chapter 3, the Infantile Spasms Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infantile Spasms Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Infantile Spasms Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Infantile Spasms Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Infantile Spasms Therapeutics Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Oral
      • 1.2.2 Injection
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Clinic
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Mallinckrodt
      • 2.1.1 Business Overview
      • 2.1.2 Infantile Spasms Therapeutics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Mallinckrodt Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 H. Lundbeck
      • 2.2.1 Business Overview
      • 2.2.2 Infantile Spasms Therapeutics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 H. Lundbeck Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Insys Therapeutics
      • 2.3.1 Business Overview
      • 2.3.2 Infantile Spasms Therapeutics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Insys Therapeutics Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Orphelia Pharma
      • 2.4.1 Business Overview
      • 2.4.2 Infantile Spasms Therapeutics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Orphelia Pharma Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Valerion Therapeutics
      • 2.5.1 Business Overview
      • 2.5.2 Infantile Spasms Therapeutics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Catalyst Pharmaceuticals
      • 2.6.1 Business Overview
      • 2.6.2 Infantile Spasms Therapeutics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Anavex Life Sciences
      • 2.7.1 Business Overview
      • 2.7.2 Infantile Spasms Therapeutics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Retrophin
      • 2.8.1 Business Overview
      • 2.8.2 Infantile Spasms Therapeutics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Retrophin Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 GW Pharmaceuticals
      • 2.9.1 Business Overview
      • 2.9.2 Infantile Spasms Therapeutics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Infantile Spasms Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Infantile Spasms Therapeutics Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Infantile Spasms Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Infantile Spasms Therapeutics Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Infantile Spasms Therapeutics Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Infantile Spasms Therapeutics Market Analysis by Regions

    • 4.1 Global Infantile Spasms Therapeutics Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Infantile Spasms Therapeutics Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Infantile Spasms Therapeutics Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 4.3 Europe Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 4.5 South America Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)

    5 North America Infantile Spasms Therapeutics by Country

    • 5.1 North America Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
      • 5.1.1 North America Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 5.3 Canada Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)

    6 Europe Infantile Spasms Therapeutics by Country

    • 6.1 Europe Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 6.3 UK Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 6.4 France Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 6.5 Russia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 6.6 Italy Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Infantile Spasms Therapeutics by Country

    • 7.1 Asia-Pacific Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
    • 7.2 China Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 7.3 Japan Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 7.4 Korea Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 7.5 India Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)

    8 South America Infantile Spasms Therapeutics by Country

    • 8.1 South America Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
      • 8.1.1 South America Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Infantile Spasms Therapeutics by Countries

    • 9.1 Middle East and Africa Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)

    10 Global Infantile Spasms Therapeutics Market Segment by Type

    • 10.1 Global Infantile Spasms Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Infantile Spasms Therapeutics Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Infantile Spasms Therapeutics Revenue and Market Share by Type (2014-2019)
    • 10.2 Oral Sales Growth and Price
      • 10.2.1 Global Oral Sales Growth (2014-2019)
      • 10.2.2 Global Oral Price (2014-2019)
    • 10.3 Injection Sales Growth and Price
      • 10.3.1 Global Injection Sales Growth (2014-2019)
      • 10.3.2 Global Injection Price (2014-2019)

    11 Global Infantile Spasms Therapeutics Market Segment by Application

    • 11.1 Global Infantile Spasms Therapeutics Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Sales Growth (2014-2019)
    • 11.3 Clinic Sales Growth (2014-2019)

    12 Infantile Spasms Therapeutics Market Forecast (2019-2024)

    • 12.1 Global Infantile Spasms Therapeutics Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Infantile Spasms Therapeutics Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Infantile Spasms Therapeutics Market Forecast (2019-2024)
      • 12.2.2 Europe Infantile Spasms Therapeutics Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Infantile Spasms Therapeutics Market Forecast (2019-2024)
      • 12.2.4 South America Infantile Spasms Therapeutics Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Infantile Spasms Therapeutics Market Forecast (2019-2024)
    • 12.3 Infantile Spasms Therapeutics Market Forecast by Type (2019-2024)
      • 12.3.1 Global Infantile Spasms Therapeutics Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Infantile Spasms Therapeutics Market Share Forecast by Type (2019-2024)
    • 12.4 Infantile Spasms Therapeutics Market Forecast by Application (2019-2024)
      • 12.4.1 Global Infantile Spasms Therapeutics Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Infantile Spasms Therapeutics Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Infantile Spasms Therapeutics . Industry analysis & Market Report on Infantile Spasms Therapeutics is a syndicated market report, published as Global Infantile Spasms Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Infantile Spasms Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,745.72
      		4,118.58
      		5,491.44
      		3,302.52
      		4,953.78
      		6,605.04
      		543,262.80
      		814,894.20
      		1,086,525.60
      		293,955.60
      		440,933.40
      		587,911.20
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo